The impact of specific mutations in TP53 gene on the results of alemtuzumab therapy in chronic lymphocytic leukemia patients

Warning

This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors

DOUBEK Michael TRBUŠEK Martin MALČÍKOVÁ Jitka BRYCHTOVÁ Yvona ŠMARDOVÁ Jana LOCHMANOVÁ Jana PANOVSKÁ Anna SKUHROVÁ FRANCOVÁ Hana MRÁZ Marek TICHÝ Boris ŠEBEJOVÁ Ludmila DOBEŠ Petr PLEVOVÁ Karla VAŇKOVÁ Gabriela KUGLÍK Petr MAYER Jiří POSPÍŠILOVÁ Šárka

Year of publication 2011
Type Conference abstract
MU Faculty or unit

Central European Institute of Technology

Citation
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info